CONNECT BIOPHARMA HLDGS LTD

Historical 13F Holders

Symbol
CNTB
CUSIP
207523101
All holders as of
Q2 2026
Type
Equity
Class
ADS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 207523101 since 12/18/2024, newest first.

Filer % of Class Filed
Wei Zheng 13G/A Amendment 6 4.0% 8/14/2026
Event 6/30/2026
Ikarian Capital, LLC 13G/A Amendment 1
6.9% 8/14/2026
Event 6/30/2026
Wei Zheng 13G/A Amendment 5 6.2% 5/15/2026
Event 3/31/2026
BioFortune Inc 13G
9.6% 4/14/2026
Event 4/14/2026
BioFortune Inc 13G/A Amendment 3
10.8% 2/17/2026
Event 12/31/2025
Zheng Wei 13G/A Amendment 4 9.0% 2/17/2026
Event 12/31/2025
Ikarian Capital, LLC 13G
8.8% 2/17/2026
Event 12/31/2025
Wei Zheng 13G/A Amendment 3 9.9% 11/28/2025
Event 11/26/2025
Panacea Innovation Ltd 13D/A Amendment 3
25.1% 7/21/2025
Event 7/21/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 1 42.3 k $101 k
2026 Q1 1 1.25 k $3.27 k
2025 Q4 1 1.29 k $3.63 k
2025 Q3 1 1.58 k $2.39 k
2025 Q2 19 2.49 M $2.44 M
2025 Q1 14 2.83 M $1.56 M
2024 Q4 16 3.18 M $4.37 M
2024 Q3 13 2.94 M $4.23 M
2024 Q2 16 2.98 M $4.53 M
2024 Q1 15 3.95 M $6.87 M
2023 Q4 17 7.12 M $8.40 M
2023 Q3 15 10.1 M $8.22 M
2023 Q2 17 10.4 M $11.7 M
2023 Q1 17 10.9 M $10.9 M
2022 Q4 21 11.1 M $9.60 M
2022 Q3 26 12.7 M $16.4 M
2022 Q2 30 15.0 M $13.0 M
2022 Q1 30 17.7 M $53.4 M
2021 Q4 33 17.0 M $87.5 M
2021 Q3 21 19.4 M $467 M
2021 Q2 17 19.1 M $372 M
2021 Q1 27 15.4 M $285 M